BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding M, Song Y, Jing J, Tian M, Ding L, Li Q, Zhou C, Dong H, Ni Y, Mou Y. The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma. Front Oncol 2021;11:719513. [PMID: 34552873 DOI: 10.3389/fonc.2021.719513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xie Y, He C, Wang W. A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis. Annals of Medicine 2022;54:3201-3210. [DOI: 10.1080/07853890.2022.2142277] [Reference Citation Analysis]
2 Qin L, Ji A, Zhou Z, Zhang Y, Xie F, Yu Y, Leng S, Li C. Preoperative lymphocyte to white blood cell ratio predicts the survival of patients with hepatocellular carcinoma after liver resection: A multicenter study.. [DOI: 10.21203/rs.3.rs-2156680/v1] [Reference Citation Analysis]
3 Zakaria SS, Ramanathan A, Mat Ripen Z, Ghani WMN, Yang Y, Vincent-chong VK, Ismail SM. Prognostic Abilities of Pre- and Post-Treatment Inflammatory Markers in Oral Squamous Cell Carcinoma: Stepwise Modelling. Medicina 2022;58:1426. [DOI: 10.3390/medicina58101426] [Reference Citation Analysis]
4 Yu C, Li Q, Zhang Y, Wen Z, Dong H, Mou Y. Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma. Front Cell Dev Biol 2022;10:941750. [DOI: 10.3389/fcell.2022.941750] [Reference Citation Analysis]
5 Hadjigol S, Shah BA, O’brien-simpson NM. The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes. Front Immunol 2022;13:894021. [DOI: 10.3389/fimmu.2022.894021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]